Trial · NCT00567502
Adverse events132
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 132
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Anaemia | Blood and lymphatic system disorders | XAGRID | 1 | 1,300 | 1 |
| serious | Anaemia | Blood and lymphatic system disorders | Other (Cytoreductives) | 9 | 3,069 | 9 |
| serious | Leukopenia | Blood and lymphatic system disorders | XAGRID | 0 | 1,300 | 0 |
| serious | Leukopenia | Blood and lymphatic system disorders | Other (Cytoreductives) | 1 | 3,069 | 1 |
| serious | Neutropenia | Blood and lymphatic system disorders | XAGRID | 0 | 1,300 | 0 |
| serious | Neutropenia | Blood and lymphatic system disorders | Other (Cytoreductives) | 1 | 3,069 | 1 |
| serious | Pancytopenia | Blood and lymphatic system disorders | XAGRID | 0 | 1,300 | 0 |
| serious | Pancytopenia | Blood and lymphatic system disorders | Other (Cytoreductives) | 2 | 3,069 | 2 |
| serious | Splenic infarction | Blood and lymphatic system disorders | XAGRID | 1 | 1,300 | 1 |
| serious | Splenic infarction | Blood and lymphatic system disorders | Other (Cytoreductives) | 1 | 3,069 | 1 |
| serious | Thrombocytopenia | Blood and lymphatic system disorders | XAGRID | 0 | 1,300 | 0 |
| serious | Thrombocytopenia | Blood and lymphatic system disorders | Other (Cytoreductives) | 2 | 3,069 | 2 |
| serious | Acute myocardial infarction | Cardiac disorders | XAGRID | 1 | 1,300 | 1 |
| serious | Acute myocardial infarction | Cardiac disorders | Other (Cytoreductives) | 1 | 3,069 | 1 |
| serious | Angina pectoris | Cardiac disorders | XAGRID | 0 | 1,300 | 0 |
| serious | Angina pectoris | Cardiac disorders | Other (Cytoreductives) | 1 | 3,069 | 1 |
| serious | Atrial fibrillation | Cardiac disorders | XAGRID | 6 | 1,300 | 6 |
| serious | Atrial fibrillation | Cardiac disorders | Other (Cytoreductives) | 0 | 3,069 | 0 |
| serious | Cardiac failure | Cardiac disorders | XAGRID | 2 | 1,300 | 2 |
| serious | Cardiac failure | Cardiac disorders | Other (Cytoreductives) | 0 | 3,069 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00567502/events